A Food and Drug Administration (FDA) advisory panel has given their approval to a new insulin delivery system for diabetics, where the insulin would be inhaled rather than injected with needles.

According to Consumer Affairs, the panel voted 7-2 to approve the system, called Exubera, for treatment of both juvenile and adult-onset diabetes. The FDA is expected to follow the recommendation

The Food and Drug Administration (FDA) has approved a "four-in-one vaccine" for children.

The new vaccine is a combination shot for measles, mumps, and rubella with a second vaccine for chickenpox

The Food and Drug Administration (FDA) has approved a "four-in-one vaccine" for children.

The new vaccine is a combination shot for measles, mumps, and rubella with a second vaccine for chickenpox

A government advisory committee is keeping a close eye on an inhaled form of insulin, designed to help millions of people with diabetes who currently rely on injections to control their blood sugar.

According to documents released by the Food and Drug Administration, chief concerns involve long-term effects on the lungs, as well as the safety of its use among smokers or sufferers of lung disease

A government advisory committee is keeping a close eye on an inhaled form of insulin, designed to help millions of people with diabetes who currently rely on injections to control their blood sugar.

According to documents released by the Food and Drug Administration, chief concerns involve long-term effects on the lungs, as well as the safety of its use among smokers or sufferers of lung disease